1. Yamada M, Li AW, Wall JR. Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit Rev Clin Lab Sci. 2000; 37:523–549.
Article
2. Bartley GB, Fatourechi V, Kadrmas EF, et al. Chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996; 121:426–434.
3. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev. 1993; 14:747–793.
Article
4. da Fonseca FL, Yamanaka PK, Mazoti L, et al. Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: a prospective comparative study. Head Neck. 2017; 39:2381–2396.
Article
5. Nowak M, Marek B, Kos-Kudła B, et al. Tear film profile in patients with active thyroid orbithopathy. Klin Oczna. 2005; 107:479–482.
6. Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017; 15:802–812.
Article
7. Eckstein AK, Finkenrath A, Heiligenhaus A, et al. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand. 2004; 82(3 Pt 1):291–297.
8. Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol (Copenh). 1983; 61:108–116.
Article
9. Iskeleli G, Karakoc Y, Abdula A. Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol. 2008; 52:323–326.
Article
10. Rocha EM, Mantelli F, Nominato LF, Bonini S. Hormones and dry eye syndrome: an update on what we do and don't know. Curr Opin Ophthalmol. 2013; 24:348–355.
11. Ahn JM, Lee SH, Rim TH, et al. Prevalence of and risk factors associated with dry eye: the Korea National Health and Nutrition Examination Survey 2010-2011. Am J Ophthalmol. 2014; 158:1205–1214.e7.
Article
12. Yoon KC, Mun GH, Kim SD, et al. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009. Korean J Ophthalmol. 2011; 25:421–433.
Article
13. Schein OD, Muñoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997; 124:723–728.
Article
14. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000; 118:1264–1268.
Article
15. Shimmura S, Shimazaki J, Tsubota K. Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. Cornea. 1999; 18:408–411.
Article
16. Chia EM, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2003; 31:229–232.
Article
17. Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002; 86:1347–1351.
Article
18. Starrenburg-Razenberg AJ, Castro Cabezas M, Gan IM, et al. Four patients with hypothyroid Graves' disease. Neth J Med. 2010; 68:178–180.
19. Sabita P, Ajit T, Narayan SD, et al. Ocular manifestations in thyroid eye disorder: a cross-sectional study from Nepal. Int J Clin Med. 2016; 7:814–823.
Article
20. Uchino M, Nishiwaki Y, Michikawa T, et al. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology. 2011; 118:2361–2367.
Article
21. Li H, Li J. Thyroid disorders in women. Minerva Med. 2015; 106:109–114.
22. Morganti S, Ceda GP, Saccani M, et al. Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest. 2005; 28:11 Suppl Proceedings. 101–104.
23. Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008; 173:600–609.
Article